Italy: market value of biopharmaceuticals 2017, by type

This statistic depicts the market value of biopharmaceuticals becoming off-patent between 2017 and 2022 in Italy as of 2017, by type. According to data, Adalimumab and Trastuzumab generated the greatest market values over the year considered, with 270 and 266 million euros, respectively.

Market value of biopharmaceuticals becoming off-patent between 2017 and 2022 in Italy as of 2017, by type

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2018

Region

Italy

Survey time period

2017

Supplementary notes

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Italy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.